Società Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE
Azioni
CBI
IL0011042806
Società Holding
Attività
Vendite per attività
ILS in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 132 | 100,0 % | 18 | 100,0 % | -86,35% |
Vendite per regione
ILS in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 132 | 100,0 % | 18 | 100,0 % | -86,35% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01/07/15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/22 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | 70 | 15/05/07 | |
Iris Sadeh
AUD | Comptroller/Controller/Auditor | - | 01/01/12 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | 67 | 09/05/03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18/11/15 |
Gad Keren
BRD | Director/Board Member | 73 | 17/02/20 |
Gabriel Barbash
BRD | Director/Board Member | 74 | 25/03/03 |
Director/Board Member | 39 | 05/12/17 | |
Nufar Malovani
BRD | Director/Board Member | 46 | 19/11/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 161 256 549 | 55 870 242 ( 34,65 %) | 4 410 349 ( 2,735 %) | 34,65 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
GAMIDA CELL LTD. 1.95% | 2 581 746 | 1.95% | 92 943 $ |
Coordinate società
Clal Biotechnology Industries Ltd.
Triangle Building Azrieli Center 3
67023, Tel Aviv
+
http://www.cbi.co.ilVariaz. 1 gen. | Capi. | |
---|---|---|
+16,98% | 75,78 Mrd | |
+59,45% | 17,7 Mrd | |
+2,74% | 15,69 Mrd | |
+8,60% | 14,04 Mrd | |
-0,04% | 12,37 Mrd | |
+8,96% | 11,98 Mrd | |
+5,82% | 10,82 Mrd | |
+34,35% | 10,08 Mrd | |
-1,92% | 9,69 Mrd |